Vazkepa 998 mg, Weichkapseln

7680683540036 CH-68354 Weichkapseln

Associated product:

VAZKEPA caps moll 998 mg bte 360 pce
Vazkepa 998 mg, Weichkapseln
Vazkepa 998 mg, Weichkapseln
Vazkepa 998 mg, Weichkapseln
1 / 3
google

Article details

Package size
360
Selling units
360
Measure
Kapsel(n)
Galenic form
Weichkapseln
Galenic group
Tabletten

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
15/03/2023
Patient information leaflet
Français
15/03/2023
Patient information leaflet
Italien
15/03/2023
Summary of Product Characteristics
Allemand
15/03/2023
Summary of Product Characteristics
Français
15/03/2023
Summary of Product Characteristics
Italien
15/03/2023

Detailed composition

Substance Quantity Type Category
CAP
998.0 MG Substance Wirkstoff (Principe actif)
CAP
- Substance ANTON
CAP
- Substance HNIDK
CAP
- Substance HNIDK
CAP
- Substance HBESI
CAP
- Substance HNIDK
CAP
- Substance HNIDK
CAP
- Substance HBESI
CAP
- Substance HNIDK
CAP
- Substance HNIDK
CAP
- Substance HNIDK
CAP
- Substance FNIDK
CAP
- Substance Hilfsstoff ohne Deklarationspflicht (Excipient sans obligation de déclaration)
CAP
- Substance HNIDK

Authorization holder

Amarin Switzerland GmbH

6300 Zug

Authorization information

Swissmedic authorization number
68354
Drug name
Vazkepa, Weichkapseln
Galenic form
KAPWE
ATC Code
C10AX06
Authorization status
Z
Dispensing category
B
First authorization
22/11/2022
Authorization expiration date
21/11/2027
IT Number
07.12.0.
Domain
Human medicine
Field of application
Blutlipidsenkende Mittel

Package details

Description (FR)
VAZKEPA caps moll 998 mg bte 360 pce
Description (DE)
VAZKEPA Weichkaps 998 mg Ds 360 Stk
Market launch
22/11/2022
Narcotic (BTM)
No

Other package sizes (2)

VAZKEPA caps moll 998 mg bte 120 pce
120 KAP
GTIN: 7680683540012
View
None
4 x 2 KAP
GTIN: None
Not in V1